Phlox Therapeutics
Phlox Therapeutics is developing Ribonucleic acid (RNA)-based gene therapies to treat cardiomyopathies, disorders that affect the heart muscle.
Naarden, Netherlandsphloxtherapeutics.com ↗
Total raised
€1.9M
€1,900,000
Funding rounds
1
Investors
5
distinct backers
Active since
2024-11
latest 2024-11
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood33
base rate 30% for Other
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-11-13 | Other | €1.9M | Amsterdam UMC Venture Holding,FIRST Fund,ROM Utrecht Region,syndicate,Utrecht Health Seed Fund (UHSF) | View deal → |
Investors
5Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- Roivant Sciences€1.2BSwitzerland · Healthtech